Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs

31.4K views
•
November 5, 2025
by
CNBC Television
YouTube video player
Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs

Transcript

Novo Nordisk is out with results this morning now lowering its fullear profit uh and revenue uh forecast. Meanwhile, uh the company it's it's getting very interesting in terms uh of uh this possible uh bidding war uh that uh that we are seeing as we move that up a little bit please. That's what this means. Yeah, there you go. Keep going. Keep going... Read More

Install to Summarize YouTube Videos and Get Transcripts

Explore YouTube Video Summarizer or Get YouTube Transcript Extractor


Read in Other Languages (beta)

Share This Summary 📚

Explore More Summaries from CNBC Television 📚